Changpeng Zhao, co-founder and former CEO of Binance, manages YZi Labs, a $10 billion investment firm, which might soon open up to external investors. Zhao’s involvement with this fund re-emerged after he completed a penalty in the United States for failing to prevent money laundering in 2023. This move signifies his return to the front lines of investment management.
YZi Labs’ Investment Strategy
YZi Labs, which became independent from Binance in early 2024, manages the assets of Zhao and other early Binance executives. The company, led by Ella Zhang and based in San Francisco, primarily focuses on cryptocurrency investments. More than 70% of YZi Labs’ portfolio is devoted to cryptocurrencies, while investments in biotechnology and artificial intelligence are also on the rise.
In 2022, YZi Labs accepted approximately $300 million in external investments but later returned some, a decision attributed to the large volume of managed assets, as explained by Zhang. According to a report by Financial Times, the company is preparing to accept external investments again, although the specifics of this process remain uncertain.
In recent times, YZi Labs has shifted its focus towards cryptocurrency treasury companies. In July, it transformed an electronic cigarette manufacturer, listed on Nasdaq, into a BNB treasury company with a $500 million investment.
Regulatory Support Boosting Interest in YZi Labs
YZi Labs closely monitors the regulatory environment in the United States. The SEC recently requested a special presentation for YZi Labs-supported companies after a New York Stock Exchange event scheduled participation with its president absent. This request highlighted the growing interest in the company’s investments.
During Trump’s administration, the U.S. adopted a more favorable approach to cryptocurrencies compared to the previous leadership, encouraging numerous ventures to return to the country. Zhang noted that many entrepreneurs have returned to Silicon Valley within this supportive environment. Nonetheless, YZi Labs’ potential acceptance of U.S. investors could entail a more rigorous oversight process moving forward.
